DNAGinkgo Bioworks Holdings, Inc.

NYSE ginkgobioworks.com


$ 0.95 $ 0.09 (10.9 %)    

Friday, 03-May-2024 15:59:58 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 0.955
$ 0.90
$ 0.00 x 0
$ 0.00 x 0
$ 0.90 - $ 0.99
$ 0.74 - $ 2.55
54,556,311
na
1.86B
$ 2.70
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-29-2024 12-31-2023 10-K
2 11-08-2023 09-30-2023 10-Q
3 08-09-2023 06-30-2023 10-Q
4 05-10-2023 03-31-2023 10-Q
5 03-13-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-16-2022 03-31-2022 10-Q
9 03-28-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
12 05-24-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 modalis-therapeutics-partners-with-ginkgo-bioworks-enhancing-cell-and-gene-therapy-with-crispr-gndm-technology

Modalis Joins Ginkgo's Technology Network Modalis Therapeutics Corporation (Modalis) (Tokyo Stock Exchange: 4883) announce...

 whats-going-on-with-ginkgo-bioworks-stock

Ginkgo Bioworks announced the expansion of its strategic partnership with Novo Nordisk A/S on Wednesday under a framework agree...

 ginkgo-bioworks-reports-acquisition-of-agbiomes-platform-assets

The deal includes over 115,000 fully sequenced and isolated strains, over 500 million unique gene sequences, and relevant funct...

 ideelab-biotechnology-enters-agreement-with-ginkgo-bioworks-to-join-ginkgo-technology-network

Ginkgo customers will now have access to IdeeLab's local strain discovery capabilities, as well as the ability to manufactu...

 ginkgo-bioworks-acquired-modulus-therapeutics-cell-therapy-assets-terms-not-disclosed

Today, Ginkgo Bioworks (NYSE:DNA), which is building the leading platform for cell programming and biosecurity, announced the a...

 why-kodiak-sciences-shares-are-trading-lower-by-around-20-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-e...

 aqua-cultured-foods-partners-with-ginkgo-bioworks-to-optimize-alt-seafood-production

AQUA Cultured Foods, a food tech company producing alternative seafood options through the use of microbial fermentation, and G...

 proteonic-biosciences-taps-ginkgo-bioworks-as-strategic-partner-and-joins-the-ginkgo-technology-network-financial-terms-undisclosed

ProteoNic Biosciences, a leading provider of premium vector technology and services for the production of biologics, today anno...

 sp-500-nasdaq-100-hit-record-highs-as-dollar-treasury-yields-weaken-chipmakers-shine-nycb-sinks-whats-driving-markets-friday

March began on a high note on Wall Street, with tech stocks driving indices to record levels. Despite weak data and mixed Fed r...

 why-zscaler-shares-are-trading-lower-by-10-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results.

 why-ginkgo-bioworks-stock-is-down-after-earnings

Ginkgo said the decrease in sales was primarily driven by the expected ramp down of K-12 testing in Ginkgo's Biosecurity se...

 td-cowen-maintains-outperform-on-ginkgo-bioworks-holdings-lowers-price-target-to-3

TD Cowen analyst Steven Mah maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Outperform and lowers the price target from...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION